John Nuss Biography and Net Worth

Insider of Ventyx Biosciences

John brings more than 25 years of small molecule drug discovery and development experience to the company, primarily in the areas of immunology, inflammation, oncology and metabolic disease. Prior to joining Ventyx, John was Vice President of Drug Discovery at the Ferring Research Institute where he was responsible for global drug discovery activities. John also previously served as Senior Vice President of Chemistry at Exelixis. Under his leadership, his teams have advanced more than 30 molecules into the clinic. He is the co-inventor of the approved therapeutics COMETRIQ^®/CABOMETYX^® and MINNEBRO^®, and led the team that discovered COTELLIC^®. Earlier in his career, he held positions of increasing responsibility in discovery at Chiron and served as an Assistant Professor of Chemistry at the University of California, Riverside. John has more than 80 publications and 30 issued patents. He received a Bachelor’s degree in Chemistry from the University of Kansas, a PhD in Organic Chemistry from the University of Wisconsin, Madison, and was an NIH postdoctoral fellow in organic synthesis at Stanford University.

What is John Nuss' net worth?: The estimated net worth of John Nuss is at least $6.84 million as of December 18th, 2025. Nuss owns 489,481 shares of Ventyx Biosciences stock worth more than $6,838,050 as of February 15th. This net worth estimate does not reflect any other investments that Nuss may own. Additionally, Nuss receives a salary of $630,630.00 as Insider at Ventyx Biosciences. Learn More about John Nuss' net worth.
How old is John Nuss?: Nuss is currently 65 years old. There are 5 older executives and no younger executives at Ventyx Biosciences. The oldest executive at Ventyx Biosciences is Dr. Raju S. Mohan Ph.D., Founder, CEO, President & Director, who is 66 years old. Learn More on John Nuss' age.
What is John Nuss' salary?: As the Insider of Ventyx Biosciences, Inc., Nuss earns $630,630.00 per year. The highest earning executive at Ventyx Biosciences is Dr. Raju S. Mohan Ph.D., Founder, CEO, President & Director, who commands a salary of $905,290.00 per year. Learn More on John Nuss' salary.
How do I contact John Nuss?: The corporate mailing address for Nuss and other Ventyx Biosciences executives is , , . Ventyx Biosciences can also be reached via phone at 760-593-4832 and via email at [email protected]. Learn More on John Nuss' contact information.
Has John Nuss been buying or selling shares of Ventyx Biosciences?: John Nuss has not been actively trading shares of Ventyx Biosciences during the last quarter. Most recently, John Nuss sold 12,675 shares of the business's stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $7.72, for a transaction totalling $97,851.00. Following the completion of the sale, the insider now directly owns 489,481 shares of the company's stock, valued at $3,778,793.32. Learn More on John Nuss' trading history.
Who are Ventyx Biosciences' active insiders?: Ventyx Biosciences' insider roster includes Sheila Gujrathi (Director), Christopher Krueger (Insider), Raju Mohan (CEO), and John Nuss (Insider). Learn More on Ventyx Biosciences' active insiders.
Are insiders buying or selling shares of Ventyx Biosciences?: During the last year, insiders at the sold shares 2 times. They sold a total of 60,020 shares worth more than $463,354.40. The most recent insider tranaction occured on December, 18th when CEO Raju Mohan sold 47,345 shares worth more than $365,503.40. Insiders at Ventyx Biosciences own 14.5% of the company. Learn More about insider trades at Ventyx Biosciences.
Information on this page was last updated on 12/18/2025.

John Nuss Insider Trading History at Ventyx Biosciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
12/18/2025	Sell	12,675	$7.72	$97,851.00	489,481
12/27/2024	Sell	21,119	$2.36	$49,840.84	464,582
12/19/2024	Sell	13,161	$2.26	$29,743.86	485,701
12/20/2023	Sell	17,628	$2.12	$37,371.36	262,118
8/3/2023	Sell	10,000	$35.60	$356,000.00	244,815
7/3/2023	Sell	20,000	$39.58	$791,600.00	244,815
5/3/2023	Sell	10,000	$38.64	$386,400.00	244,815
12/22/2022	Sell	13,812	$31.61	$436,597.32	244,815
12/5/2022	Sell	50,000	$28.23	$1,411,500.00	258,696

John Nuss Buying and Selling Activity at Ventyx Biosciences

Ventyx Biosciences Company Overview

Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates to address a range of inflammatory diseases. The company's lead clinical product candidate is VTX958, a selective allosteric tyrosine kinase type 2 inhibitor for psoriasis, psoriatic arthritis, and Crohn's disease. It is also developing VTX002, a sphingosine 1 phosphate receptor modulator that is in Phase II clinical trials for the treatment of ulcerative colitis; and VTX2735, a peripheral-targeted NOD-like receptor protein 3 inflammasome inhibitor to treat patients with cryopyrin-associated periodic syndrome. In addition, the company develops VTX3232, a CNS-penetrant NLRP3 inhibitor. Ventyx Biosciences, Inc. was incorporated in 2018 and is based in San Diego, California.

Today's Range

Now: $13.97

$13.93

$13.97

50 Day Range

MA: $11.63

$7.69

$14.03

2 Week Range

Now: $13.97

$0.78

$25.00

Volume

2,530,427 shs

Average Volume

2,201,694 shs

Market Capitalization

$1.00 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.25

John Nuss Biography and Net Worth

What is John Nuss' net worth?

How old is John Nuss?

What is John Nuss' salary?

How do I contact John Nuss?

Has John Nuss been buying or selling shares of Ventyx Biosciences?

Who are Ventyx Biosciences' active insiders?

Are insiders buying or selling shares of Ventyx Biosciences?